Connection

Marc Lipman to Humans

Back to Details
This is a "connection" page, showing publications Marc Lipman has written about Humans.
Marc Lipman
Connection Strength
0.111
Humans
  1. The impact of COVID-19 on global tuberculosis control. Indian J Med Res. 2021 04; 153(4):404-408.
    View in: PubMed
    Score: 0.008
  2. Contact tracing for SARS-CoV-2: what can be learned from other conditions? Clin Med (Lond). 2021 03; 21(2):e132-e136.
    View in: PubMed
    Score: 0.007
  3. SARS-CoV-2 pandemic: clinical picture of COVID-19 and implications for research. Thorax. 2020 08; 75(8):614-616.
    View in: PubMed
    Score: 0.007
  4. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann Clin Microbiol Antimicrob. 2020 May 23; 19(1):21.
    View in: PubMed
    Score: 0.007
  5. Update in Tuberculosis and Nontuberculous Mycobacteria 2017. Am J Respir Crit Care Med. 2018 05 15; 197(10):1248-1253.
    View in: PubMed
    Score: 0.006
  6. Can somatic GATA2 mutation mimic germ line GATA2 mutation? Blood Adv. 2018 04 24; 2(8):904-908.
    View in: PubMed
    Score: 0.006
  7. Access to influenza immunisation services by HIV-positive patients in the UK. Influenza Other Respir Viruses. 2018 07; 12(4):544-546.
    View in: PubMed
    Score: 0.006
  8. Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results. Eur Respir J. 2017 10; 50(4).
    View in: PubMed
    Score: 0.006
  9. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. Int J Infect Dis. 2015 Mar; 32:39-45.
    View in: PubMed
    Score: 0.005
  10. Detection of mycobacterial antigen responses in lung but not blood in HIV-tuberculosis co-infected subjects. AIDS. 2006 Jun 12; 20(9):1330-2.
    View in: PubMed
    Score: 0.003
  11. Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts. J Infect. 2005 Dec; 51(5):419-20.
    View in: PubMed
    Score: 0.003
  12. Reducing the risk of tuberculosis transmission for HCWs in high incidence settings. Antimicrob Resist Infect Control. 2021 07 19; 10(1):106.
    View in: PubMed
    Score: 0.002
  13. Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease. Lancet Respir Med. 2021 09; 9(9):947-949.
    View in: PubMed
    Score: 0.002
  14. The high mental health burden of "Long COVID" and its association with on-going physical and respiratory symptoms in all adults discharged from hospital. Eur Respir J. 2021 06; 57(6).
    View in: PubMed
    Score: 0.002
  15. World Tuberculosis Day 2021 Theme - 'The Clock is Ticking' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic. Int J Infect Dis. 2021 12; 113 Suppl 1:S1-S6.
    View in: PubMed
    Score: 0.002
  16. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. 2021 04; 9(4):349-359.
    View in: PubMed
    Score: 0.002
  17. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. Eur Respir J. 2020 12; 56(6).
    View in: PubMed
    Score: 0.002
  18. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021 04; 76(4):396-398.
    View in: PubMed
    Score: 0.002
  19. Descriptive account of 18 adults with known HIV infection hospitalised with SARS-CoV-2 infection. Sex Transm Infect. 2021 08; 97(5):392-393.
    View in: PubMed
    Score: 0.002
  20. The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions. Lancet Respir Med. 2020 05; 8(5):438-440.
    View in: PubMed
    Score: 0.002
  21. Effectiveness of BCG Vaccination Against Mycobacterium tuberculosis Infection in Adults: A Cross-sectional Analysis of a UK-Based Cohort. J Infect Dis. 2020 01 01; 221(1):146-155.
    View in: PubMed
    Score: 0.002
  22. Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance. Eur Respir J. 2019 10; 54(4).
    View in: PubMed
    Score: 0.002
  23. Individualising therapy for drug-sensitive tuberculosis. Lancet Respir Med. 2019 10; 7(10):834-835.
    View in: PubMed
    Score: 0.002
  24. Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-LOndon Ocular tuberculosis Pathway-LOOP. Eye (Lond). 2020 05; 34(5):805-808.
    View in: PubMed
    Score: 0.002
  25. Revolutionary new treatment regimens for multidrug-resistant tuberculosis. Lancet Infect Dis. 2019 03; 19(3):233-234.
    View in: PubMed
    Score: 0.002
  26. Clinical utility of existing and second-generation interferon-? release assays for diagnostic evaluation of tuberculosis: an observational cohort study. Lancet Infect Dis. 2019 02; 19(2):193-202.
    View in: PubMed
    Score: 0.002
  27. Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing. J Clin Microbiol. 2018 08; 56(8).
    View in: PubMed
    Score: 0.002
  28. Trends in, and factors associated with, HIV infection amongst tuberculosis patients in the era of anti-retroviral therapy: a retrospective study in England, Wales and Northern Ireland. BMC Med. 2018 06 07; 16(1):85.
    View in: PubMed
    Score: 0.002
  29. Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort. Thorax. 2019 01; 74(1):91-94.
    View in: PubMed
    Score: 0.002
  30. High mortality in patients with Mycobacterium avium complex lung disease: a systematic review. BMC Infect Dis. 2018 05 03; 18(1):206.
    View in: PubMed
    Score: 0.002
  31. Resilience and Physical and Mental Well-Being in Adults with and Without HIV. AIDS Behav. 2018 05; 22(5):1688-1698.
    View in: PubMed
    Score: 0.002
  32. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study. Int J Epidemiol. 2018 02 01; 47(1):193-201.
    View in: PubMed
    Score: 0.002
  33. High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population. Thorax. 2018 06; 73(6):557-564.
    View in: PubMed
    Score: 0.002
  34. Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV. AIDS. 2017 11 13; 31(17):2403-2413.
    View in: PubMed
    Score: 0.001
  35. Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis. Eur Respir J. 2017 10; 50(4).
    View in: PubMed
    Score: 0.001
  36. Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2017 09; 61(9).
    View in: PubMed
    Score: 0.001
  37. Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis. Ann Intern Med. 2017 Aug 15; 167(4):248-255.
    View in: PubMed
    Score: 0.001
  38. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK. Health Technol Assess. 2017 07; 21(39):1-54.
    View in: PubMed
    Score: 0.001
  39. Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014. J Infect. 2017 03; 74(3):260-271.
    View in: PubMed
    Score: 0.001
  40. What's new in respiratory infections and tuberculosis 2008-2010. Thorax. 2012 Apr; 67(4):350-4.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.